相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo
Zev A. Wainberg et al.
CLINICAL CANCER RESEARCH (2010)
CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance
Do Youn Park et al.
MODERN PATHOLOGY (2010)
Synergistic Antitumor Effect of S-1 and HER2-Targeting Agents in Gastric Cancer with HER2 Amplification
Junko Tanizaki et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Epstein-Barr virus and gastric carcinoma
Masashi Fukayama
PATHOLOGY INTERNATIONAL (2010)
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Ying Jiang et al.
BLOOD (2009)
E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man
Bostjan Humar et al.
CANCER RESEARCH (2009)
Activation of DNA Methyltransferase 1 by EBV Latent Membrane Protein 2A Leads to Promoter Hypermethylation of PTEN Gene in Gastric Carcinoma
Rumi Hino et al.
CANCER RESEARCH (2009)
Hereditary diffuse gastric cancer: A manifestation of lost cell polarity
Bostjan Humar et al.
CANCER SCIENCE (2009)
Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma
Chang Do Jee et al.
EUROPEAN JOURNAL OF CANCER (2009)
Nature meets nurture: molecular genetics of gastric cancer
Anya N. Milne et al.
HUMAN GENETICS (2009)
HER-2 amplification is highly homogenous in gastric cancer
Andreas H. Marx et al.
HUMAN PATHOLOGY (2009)
Survival advantage of ERV-associated gastric carcinoma: Survivin up-regulation by viral latent membrane protein 2A
Rumi Hino et al.
CANCER RESEARCH (2008)
Helicobacter pylori, inflammation, oxidative damage and gastric cancer:: a morphological, biological and molecular pathway
Fabio Farinati et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival
Mario Falchetti et al.
HUMAN PATHOLOGY (2008)
IL-1B-31T > C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers
R. Sitarz et al.
VIRCHOWS ARCHIV (2008)
CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer
Qiang Liu et al.
MODERN PATHOLOGY (2007)
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
Yuko Matsumoto et al.
NATURE MEDICINE (2007)
Suppression of gastric cancer cell growth by targeting the β-catenin/T-cell factor pathway
Hadas Dvory-Sobol et al.
CANCER (2007)
Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction
Min A. Kim et al.
HUMAN PATHOLOGY (2007)
RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer
Zhihai Peng et al.
CLINICAL CANCER RESEARCH (2006)
HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with gastric cancer
T. Inui et al.
JOURNAL OF INTERNAL MEDICINE (2006)
HER-2/neu amplification is an independent prognostic factor in gastric cancer
Dong Il Park et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor β-induced apoptosis
Takashi Yano et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome C release and cell death, independent of vacuolation
E Yamasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Helicobacter pylori infection and gastric cancer
T Matysiak-Budnik et al.
EUROPEAN JOURNAL OF CANCER (2006)
Hereditary diffuse gastric cancer: Diagnosis and management
V Blair et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions
HS Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Pathology and molecular biology of gastric cancer
Matti Vauhkonen et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2006)
Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2 '-deoxycytidine treatment and oligonucleotide microarray
S Yamashita et al.
CANCER SCIENCE (2006)
The epigenetic progenitor origin of human cancer
AP Feinberg et al.
NATURE REVIEWS GENETICS (2006)
Novel targeted therapies in the treatment of gastric and esophageal cancer
J Tabernero et al.
ANNALS OF ONCOLOGY (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Tumor microsatellite instability in early onset gastric cancer
J Bacani et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers
C Sakakura et al.
CLINICAL CANCER RESEARCH (2005)
RUNX3 suppresses gastric epithelial cell growth by inducing p21WAF1/Cip1 expression in cooperation with transforming growth factor β-activated SMAD
XZ Chi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes
J Motoshita et al.
CANCER SCIENCE (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Amplification of HER-2 in gastric carcinoma:: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
M Tanner et al.
ANNALS OF ONCOLOGY (2005)
Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma
TY Kim et al.
LABORATORY INVESTIGATION (2004)
Epstein-Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma
HS Lee et al.
CLINICAL CANCER RESEARCH (2004)
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
U Cavallaro et al.
NATURE REVIEWS CANCER (2004)
Latent membrane protein 2A inhibits transforming growth factor-β1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway
M Fukuda et al.
JOURNAL OF VIROLOGY (2004)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
DNA hypermethylation in gastric cancer
TY Kim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Development of gastric carcinoma from intestinal metaplasia in CDx2-transgenic mice
H Mutoh et al.
CANCER RESEARCH (2004)
Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer
M Ueno et al.
TUMOR BIOLOGY (2004)
CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene
YQ Bai et al.
ONCOGENE (2003)
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma
JC Machado et al.
GASTROENTEROLOGY (2003)
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
EM El-Omar et al.
GASTROENTEROLOGY (2003)
Profile of aberrant CpG island methylation along multistep gastric carcinogenesis
GH Kang et al.
LABORATORY INVESTIGATION (2003)
TP53 and gastric carcinoma: A review
CM Fenoglio-Preiser et al.
HUMAN MUTATION (2003)
Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis
T Mizoshita et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer
KF To et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Medical progress:: Helicobacter pylori infection
S Suerbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase
SY Chen et al.
JOURNAL OF VIROLOGY (2002)
Distinct clinical features and outcomes of gastric cancers with microsatellite instability
HS Lee et al.
MODERN PATHOLOGY (2002)
Causal relationship between the loss of RUNX3 expression and gastric cancer
QL Li et al.
CELL (2002)
Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach
YQ Bai et al.
CANCER LETTERS (2002)
SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein
H Higashi et al.
SCIENCE (2002)
Gastrointestinal cancer of the microsatellite mutator phenotype pathway
H Yamamoto et al.
JOURNAL OF GASTROENTEROLOGY (2002)
Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma
GH Kang et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Cdx2 ectopic expression induced gastric intestinal metaplasia in transgenic mice
DG Silberg et al.
GASTROENTEROLOGY (2002)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
DG Huntsman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma
JC Machado et al.
ONCOGENE (2001)
Chemoprevention of gastric dysplasia:: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy
P Correa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
